Physician

James Tucker Osteen, M.D.

According to 2025 Medicare claims, James Osteen, M.D. (NPI: 1407234453) practices internal medicine in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79124-2167. Osteen is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Osteen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 903 traditional Medicare patients, billed 232,646 HCPCS/CPT codes, and received $2,464,582 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,139 prescription claims across 171 beneficiaries totaling $2,858,454 in drug costs, led by Calquence (Acalabrutinib Maleate). Open Payments data shows 8 records totaling $220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,124 to $2,858,454. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2021 Medicare payment: $955,135 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,727,187 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,909,816 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,464,582 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202140171,264$955,135
2022840255,214$2,727,187
2023870290,375$2,909,816
2024903232,646$2,464,582

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2015 Drug cost: $2,124 (USD; Tot_Drug_Cst)2016 Drug cost: $11,149 (USD; Tot_Drug_Cst)2017 Drug cost: $12,636 (USD; Tot_Drug_Cst)2018 Drug cost: $7,031 (USD; Tot_Drug_Cst)2020 Drug cost: $35,222 (USD; Tot_Drug_Cst)2021 Drug cost: $27,141 (USD; Tot_Drug_Cst)2022 Drug cost: $1,138,850 (USD; Tot_Drug_Cst)2023 Drug cost: $1,950,767 (USD; Tot_Drug_Cst)2024 Drug cost: $2,858,454 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151131$2,124
201633256$11,149
201723181$12,636
201822139$7,031
2019N/RN/RN/R
20201219$35,222
20212647$27,141
2022121662$1,138,850
2023165934$1,950,767
20241711,139$2,858,454

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more212426$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more225291$62
80053Blood test, comprehensive group of blood chemicals3851,051$10
36415Insertion of needle into vein for collection of blood sample3691,035$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3691,072$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate421,260$638,649
TasignaNilotinib Hcl27756$509,269
BrukinsaZanubrutinib351,050$496,698
RevlimidLenalidomide26723$458,524
JakafiRuxolitinib Phosphate17510$269,454

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$220AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Tucker Osteen, M.D.?

Tedicare shows public-source Medicare data for James Tucker Osteen, M.D. (NPI 1407234453), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Tucker Osteen, M.D. have ACO affiliation data?

James Tucker Osteen, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James Tucker Osteen, M.D.?

James Tucker Osteen, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does James Tucker Osteen, M.D. have Open Payments data?

James Tucker Osteen, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.